Screening for cervical cancer: Choices & dilemmas

被引：33
作者：
Rajaram, Shalini [1 ,3 ]
Gupta, Bindiya [2 ]
机构：
[1] All India Inst Med Sci, Dept Obstet & Gynecol, Rishikesh, Uttarakhand, India
[2] Univ Coll Med Sci & Guru Teg Bahadur Hosp, Delhi, India
[3] AIIMS Rishikesh, Dept Obstet & Gynecol, Veerbhadra Rd, Rishikesh 249203, Uttaranchal, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2021年 / 154卷 / 02期
关键词：
Biomarker; cervical cancer screening; cervical cytology; DNA methylation; HPV DNA testing; p16/Ki 67 dual staining; VIA; HUMAN-PAPILLOMAVIRUS DNA; HPV-POSITIVE WOMEN; LIQUID-BASED CYTOLOGY; EXTENDED FOLLOW-UP; CLINICAL-PERFORMANCE; VISUAL INSPECTION; ACETIC-ACID; INTRAEPITHELIAL NEOPLASIA; BASE-LINE; RISK;
D O I：
10.4103/ijmr.IJMR_857_20
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and visual inspection tests. Precision tests, including molecular and protein biomarkers such as DNA methylation, p16 immunostaining, and HPV mRNA testing help to enhance specificity of the screening. Worldwide HPV DNA testing with or without cytology is used as a screening method of choice, while in resource-poor settings, visual inspection tests are recommended. The major hurdle is a uniform and systematic implementation with a recall method in the population. Besides, controversies still exist regarding strategies to manage HPV-positive women and developing guidelines to screen the vaccinated population.
引用
收藏
页码：210 / 220
页数：11
相关论文
共 79 条
  • [1] Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review
    Adsul, Prajakta
    Manjunath, Nitin
    Srinivas, Vijaya
    Arun, Anjali
    Madhivanan, Purnima
    [J]. CANCER EPIDEMIOLOGY, 2017, 49 : 161 - 174
  • [2] [Anonymous], CERVICAL CANC SCREEN
  • [3] [Anonymous], OP FRAM MAN COMM CAN
  • [4] Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India
    Arbyn, Marc
    Sankaranarayanan, Rengaswamy
    Muwonge, Richard
    Keita, Namory
    Dolo, Amadou
    Mbalawa, Charles Gombe
    Nouhou, Hassan
    Sakande, Boblewende
    Wesley, Ramani
    Somanathan, Thara
    Sharma, Anjali
    Shastri, Surendra
    Basu, Parthasarathy
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (01) : 153 - 160
  • [5] The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy
    Arbyn, Marc
    Roelens, Jolien
    Cuschieri, Kate
    Cuzick, Jack
    Szarewski, Ann
    Ratnam, Sam
    Reuschenbach, Miriam
    Belinson, Suzanne
    Belinson, Jerome L.
    Monsonego, Joseph
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (01) : 101 - 108
  • [6] Early Impact of Human Papillomavirus Vaccination on Cervical NeoplasiauNationwide Follow-up of Young Danish Women
    Baldur-Felskov, Birgitte
    Dehlendorff, Christian
    Munk, Christian
    Kjaer, Susanne K.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (03):
  • [7] Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings
    Basu, Partha
    Meheus, Filip
    Chami, Youssef
    Hariprasad, Roopa
    Zhao, Fanghui
    Sankaranarayanan, Rengaswamy
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 138 : 26 - 32
  • [8] Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla, Neerja
    Dar, Lalit
    Patro, A. Rajkumar
    Kumar, Pankaj
    Kriplani, Alka
    Gulati, Arti
    Iyer, Venkateswaran K.
    Mathur, Sandeep R.
    Sreenivas, Vishnubhatla
    Shah, Keerti V.
    Gravitt, Patti E.
    [J]. CANCER EPIDEMIOLOGY, 2009, 33 (06) : 446 - 450
  • [9] Screening and management of preinvasive lesions of the cervix: Good clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI)
    Bhatla, Neerja
    Singhal, Seema
    Saraiya, Usha
    Srivastava, Shikha
    Bhalerao, Sarita
    Shamsunder, Saritha
    Chavan, Niranjan
    Basu, Partha
    Purandare, C. N.
    Agarwal, P.
    Arora, M.
    Bhatla, N.
    Basu, P.
    Bhalerao, S.
    Batra, S.
    Banerjee, D.
    Chavan, N.
    Dhorepatil, B.
    Gupta, B.
    Gandhi, G.
    Gupta, K.
    Ganesh, P.
    Joshi, S.
    Kriplani, A.
    Khanna, R.
    Kumar, S.
    Maheshwari, A.
    Meena, J.
    Nayak, B.
    Natarajan, J.
    Pai, R.
    Pathak, R.
    Prabhu, R. B.
    Peedicayil, A.
    Rajaram, S.
    Sekhon, R.
    Shamsunder, S.
    Srivastava, S.
    Singh, U.
    Singhal, S.
    Saraiya, U.
    Zutshi, V.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2020, 46 (02) : 201 - 214
  • [10] Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
    Brisson, Marc
    Kim, Jane J.
    Canfell, Karen
    Drolet, Melanie
    Gingras, Guillaume
    Burger, Emily A.
    Martin, Dave
    Simms, Kate T.
    Benard, Elodie
    Boily, Marie-Claude
    Sy, Stephen
    Regan, Catherine
    Keane, Adam
    Caruana, Michael
    Nguyen, Diep T. N.
    Smith, Megan A.
    Laprise, Jean-Francois
    Jit, Mark
    Alary, Michel
    Bray, Freddie
    Fidarova, Elena
    Elsheikh, Fayad
    Bloem, Paul J. N.
    Broutet, Nathalie
    Hutubessy, Raymond
    [J]. LANCET, 2020, 395 (10224) : 575 - 590
12345678